{
  "canonical": "https://smarthernews.com/article/j-j-covid-vaccine-pause/",
  "ogUrl": "https://smarthernews.com/article/j-j-covid-vaccine-pause/",
  "ogTitle": "johnson & johnson, becoming at least the second company to pause its covid-19 clinical vaccine trial, due to an unexplained illness in a participant. - smarther news",
  "ogDescription": "we have temporarily paused further dosing in all our covid-19 vaccine candidate clinical trials...",
  "ogImage": "https://smarthernews.com/wp-content/uploads/2018/04/lab-2107510_1920.jpg",
  "datePublished": "2020-10-13T17:02:22+00:00",
  "dateModified": "2020-10-13T18:07:09+00:00",
  "articleSection": "quick quotes",
  "quote": "We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials...",
  "summary": "Johnson & Johnson, becoming at least the second company to pause its COVID-19 clinical vaccine trial, due to an unexplained illness in a participant.",
  "featured_image": {
    "imageUrl": "https://smarthernews.com/wp-content/uploads/2018/04/lab-2107510_1920.jpg",
    "alt": ""
  },
  "body": "<ul> <li>On October 12, Johnson &amp; Johnson (J&amp;J) <a href=\"https://www.jnj.com/our-company/johnson-johnson-temporarily-pauses-all-dosing-in-our-janssen-covid-19-vaccine-candidate-clinical-trials\">announced</a> it will pause all of its single-dose and two-dose regimen trials, including its Phase III <a href=\"https://www.jnj.com/coronavirus/covid-19-phase-3-study-clinical-protocol\">ENSEMBLE</a> trial, which began in September and aimed to enroll up to 60,000 participants. <ul> <li>We don’t know exactly what the “unexplained illness” involves, but J&amp;J notes that study pauses due to adverse events are common. <ul> <li>&nbsp;Just last month, U.K.- based drug company, AstraZeneca paused its Phase III vaccine trials worldwide due to an unexplained illness. Trials have resumed in many countries, including the United Kingdom, but not in America.</li> </ul> </li> <li>On Tuesday, J&amp;J’s head of research &amp; development <a href=\"https://www.reuters.com/article/us-health-coronavirus-johnson-johnson/jj-says-review-of-illness-that-led-to-pause-of-coronavirus-vaccine-trial-could-take-days-idUSKBN26Y01Q\">said</a> the company is investigating the matter, but that he doesn’t know whether the participant received the vaccine or a placebo.</li> </ul> </li> <li>It can take up to a decade for vaccines to go through the research and approval process, but J&amp;J said it hopes to be able to supply over a 1 billion vaccine doses next year .</li> <li><strong>BIG PICTURE: </strong>There’s a historic vaccine development race underway,&nbsp;with more than <a href=\"https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html\">40</a> COVID-19 vaccine clinical trials currently underway. About a quarter of those trials are Phase III (the last stage before approval) – including at least two now-paused J&amp; J trials.</li> </ul>",
  "contentType": "quickquotes"
}